Heterologous Prime-Boost Enhances the Antitumor Immune Response Elicited by Plant-Virus-Based Cancer Vaccine

Overview of attention for article published in Journal of the American Chemical Society, April 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

twitter: 13 X users

Citations

dimensions_citation: 58 Dimensions

Readers on

mendeley: 54 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 18 X posts from 13 X users, with an upper bound of 172,764 followers.

RT @NF_Steinmetz: our heterologous prime-boost vaccine (https://t.co/6GWTDKEYr9) was highlighted in Nature Reviews Materials https://t.co/B…

21 May 2019

Reply Repost Favourite

RT @NF_Steinmetz: our heterologous prime-boost vaccine (https://t.co/6GWTDKEYr9) was highlighted in Nature Reviews Materials https://t.co/B…

15 May 2019

Reply Repost Favourite

Retweeting again to highlight this great work! Combination of #plant #viruses used for a #vaccine against #cancer. Brilliant idea to use multiple carriers to make sure immune response is strongest against the target (cancer) and not the delivery vehicle!

15 May 2019

Reply Repost Favourite

RT @NF_Steinmetz: our heterologous prime-boost vaccine (https://t.co/6GWTDKEYr9) was highlighted in Nature Reviews Materials https://t.co/B…

15 May 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 14 additional X posts.